![Urs Tuor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Urs Tuor
Nessuna posizione attualmente
Profilo
Urs Tuor is Director of Marketing and Business Development for GlycoVaxyn AG.
Prior to co-founding GlycoVaxyn in 2004, he worked at Bank Sarasin & Cie AG.
Before Bank Sarasin, Dr. Tuor was Director of Applied Research for the Institute of Microbiology of the ETH.
He received a PhD from the Swiss Federal Institute of Technology.
Precedenti posizioni note di Urs Tuor
Società | Posizione | Fine |
---|---|---|
Bank Sarasin & Cie AG (Broker) | Analyst-Equity | 30/08/2004 |
Bank Sarasin & Cie. AG
![]() Bank Sarasin & Cie. AG Major BanksFinance Bank Sarasin & Cie. AG provides banking services. The Private Banking segment is responsible for the acquisition, service and support of customers in the global private client business. The Trading & Family Offices segment handles the provision of advice to family offices and external asset managers at all Sarasin Group locations. The Asset Management, Products & Sales segment provides services to institutional clients and distribution partners in the wholesale area at all the Sarasin Group's locations. The Bank Weiplus segment is in charge of the operations made by Bank Weiplus Ltd., a business that is fully consolidated with in the group. The Corporate Center segment handles all the internal support functions for the Sarasin Group. It was founded by Johannes Riggenbach on February 20, 1841 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
GlycoVaxyn AG
![]() GlycoVaxyn AG BiotechnologyHealth Technology GlycoVaxyn AG developed and produced bioconjugate vaccines. The company was founded in 2004 and was headquartered in Schlieren, Switzerland. | Fondatore | - |
Formazione di Urs Tuor
Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Società collegate
Aziende private | 3 |
---|---|
GlycoVaxyn AG
![]() GlycoVaxyn AG BiotechnologyHealth Technology GlycoVaxyn AG developed and produced bioconjugate vaccines. The company was founded in 2004 and was headquartered in Schlieren, Switzerland. | Health Technology |
Bank Sarasin & Cie. AG
![]() Bank Sarasin & Cie. AG Major BanksFinance Bank Sarasin & Cie. AG provides banking services. The Private Banking segment is responsible for the acquisition, service and support of customers in the global private client business. The Trading & Family Offices segment handles the provision of advice to family offices and external asset managers at all Sarasin Group locations. The Asset Management, Products & Sales segment provides services to institutional clients and distribution partners in the wholesale area at all the Sarasin Group's locations. The Bank Weiplus segment is in charge of the operations made by Bank Weiplus Ltd., a business that is fully consolidated with in the group. The Corporate Center segment handles all the internal support functions for the Sarasin Group. It was founded by Johannes Riggenbach on February 20, 1841 and is headquartered in Basel, Switzerland. | Finance |
Bank Sarasin & Cie AG (Broker) | Finance |
- Borsa valori
- Insiders
- Urs Tuor